Compounds > furosemide

furosemide and naringenin

furosemide has been researched along with naringenin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR1
Lorenzo, B; Reidenberg, MM; Zhang, YD1
Hult, M; Jörnvall, H; Oppermann, UC1

Reviews

1 review(s) available for furosemide and naringenin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

4 other study(ies) available for furosemide and naringenin

ArticleYear
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
    Journal of medicinal chemistry, 2008, Jun-12, Volume: 51, Issue:11

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship

2008
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
    Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10

    Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection

2012
Inhibition of 11 beta-hydroxysteroid dehydrogenase obtained from guinea pig kidney by furosemide, naringenin and some other compounds.
    The Journal of steroid biochemistry and molecular biology, 1994, Volume: 49, Issue:1

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cholic Acids; Cortisone; Estrogen Antagonists; Flavanones; Flavonoids; Furosemide; Glycyrrhetinic Acid; Glycyrrhizic Acid; Guinea Pigs; Hydrocortisone; Hydroxysteroid Dehydrogenases; In Vitro Techniques; Kidney Cortex; Kinetics; Male; Microsomes; Sterols

1994
Selective inhibition of human type 1 11beta-hydroxysteroid dehydrogenase by synthetic steroids and xenobiotics.
    FEBS letters, 1998, Dec-11, Volume: 441, Issue:1

    Topics: 11-beta-Hydroxysteroid Dehydrogenases; Cloning, Molecular; Enzyme Inhibitors; Estradiol Congeners; Flavanones; Flavonoids; Furosemide; Humans; Hydroxysteroid Dehydrogenases; Kinetics; Microsomes; Pichia; Recombinant Proteins; Steroids; Substrate Specificity; Xenobiotics

1998